An evidence review
How to Inject Sermorelin (Step-by-Step, Honestly)
A source-anchored walk-through of reconstituting and subcutaneously injecting compounded sermorelin — and why the dose must come from your prescriber.
Written by
Adrian ColeLead Research Editor
Adrian Cole is the pen name of Somnipeptide's lead research editor, who writes about growth-hormone secretagogues, sleep architecture, recovery, and longevity peptides.
Every claim cited to primary research ·
Sermorelin is supplied as a lyophilized powder that has to be reconstituted and injected under the skin — there is no pill, patch or oral version that meaningfully works (we explain why in do oral and sublingual sermorelin actually work?). If a clinician has prescribed it for you, the mechanics of mixing and injecting it are not complicated. But two things need saying up front, before any step-by-step. First: this is a procedure guide, not a prescription. The drug, the dose, the schedule and the decision to use it at all are your prescriber's to set and monitor — nothing on this page substitutes for the instructions on your own vial. Second: sermorelin today is a compounded, off-label peptide, not an FDA-approved finished drug, so the exact concentration in your vial, the diluent volume and the storage rules depend on the compounding pharmacy that made it. Always follow the label and patient instructions you were given over any generic guide, including this one.
With those guardrails in place, here is what the process actually involves and where the evidence-anchored facts come from.
What sermorelin is, and why it's injected subcutaneously
Sermorelin is GHRH(1-29) — the shortest fragment of growth-hormone-releasing hormone that still works — and like the rest of its drug class it is given by subcutaneous (under-the-skin) injection, not by mouth1. There is a hard pharmacological reason it isn't a tablet: native GHRH(1-29) is cleared from the blood within minutes because enzymes break it down almost immediately2. That fragility is exactly why researchers built longer-acting analogs to get a sustained signal3, and it's why a swallowed or sublingual peptide is degraded before it can do much. A small-volume injection into subcutaneous fat is the route that reliably delivers it.
The studied regimens reflect this. In the pediatric growth-hormone-deficiency trials that produced sermorelin's clearest dosing data, it was given as a once-daily subcutaneous injection at bedtime4, and the elderly-men study that most resembles adult off-label use also used nightly subcutaneous injections5. Bedtime timing is deliberate — it's meant to reinforce your natural nighttime growth-hormone pulse, which is also why sermorelin's plausible effects cluster around sleep rather than daytime performance. We unpack that in our pillar guide to sermorelin for sleep, recovery and healthy aging and in sermorelin and deep sleep.
Before you start: dose and storage come from your pharmacy, not a chart
There is no validated adult "anti-aging" dose of sermorelin — the confident dosage charts online are extrapolations, not trial findings, and we lay out the actual evidence in sermorelin dosing: what the research supports. So the single most important pre-injection step is to read your own prescription: the concentration of your reconstituted vial and the number of units or milliliters to draw are set by your prescriber and compounding pharmacy. Do not infer a dose from a forum.
Storage matters too, and it's a place where compounded sermorelin differs from an approved analog. The FDA-approved GHRH-analog drug tesamorelin (EGRIFTA SV) stores its lyophilized powder at room temperature and is mixed only at the time of use6. Compounded sermorelin, by contrast, is commonly shipped and stored refrigerated, and the lyophilized vial is typically kept cold both before and after reconstitution — but because the formulation is pharmacy-specific, the only storage rule that counts is the one printed on your vial. (For how compounded sermorelin's handling differs from the FDA-approved analog, see tesamorelin vs sermorelin.)
You'll generally need, all supplied or specified by your pharmacy: the sermorelin vial, the correct diluent (usually bacteriostatic or sterile water for injection), a reconstitution syringe, insulin syringes with short fine needles for the injections, alcohol swabs, and a sharps container.
Reconstitution: mixing the powder gently
Reconstitution is the step people most often rush. The model to copy is the one written into the approved tesamorelin label, because the chemistry is the same class of fragile peptide: inject the specified small volume of diluent slowly down the inside wall of the vial, then mix by rolling the vial gently between your hands — do not shake it6. Shaking or squirting diluent directly onto the powder can foam and denature the peptide. Let it dissolve fully into a clear solution before drawing any out; if it stays cloudy or has visible particles, don't use it.
Two practical points follow from the pharmacology. Because reconstituted GHRH peptide is not indefinitely stable, the approved analog's label tells patients not to freeze the mixed solution and to use it appropriately rather than storing it open-endedly6 — your compounded sermorelin will carry its own beyond-use date, and you should respect it. And because the molecule is delicate, gentle handling throughout (no shaking, no heat, no freezing unless your pharmacy specifies) is part of getting the dose you think you're getting.
The injection: a standard subcutaneous self-injection
Once reconstituted and drawn to your prescribed dose, sermorelin is given like any other small-volume subcutaneous injection, and the technique that matters is well established from diabetes-care injection guidance. The consensus recommendations on subcutaneous injection emphasize a few things that apply directly here: use a short, fine needle; rotate injection sites with each dose to avoid lipohypertrophy (the lumpy, scarred tissue that forms when you inject the same spot repeatedly and that can erratically change absorption); and follow a clean technique7. The approved tesamorelin label gives the same site-rotation instruction for an abdominal subcutaneous GHRH injection6.
In practice that means: wash your hands; swab the site (commonly the abdomen, a couple of inches from the navel, or the thigh) and let it dry; with a short insulin needle, modern guidance for most adults is to inject straight in at 90 degrees, using a lifted skin fold if you are lean, to keep the dose in the subcutaneous fat rather than muscle7; depress the plunger slowly; withdraw; and dispose of the needle in a sharps container without recapping. Rotate to a fresh site the next night. None of this is sermorelin-specific — it is ordinary subcutaneous injection technique — but doing it cleanly and rotating sites is what keeps absorption consistent and the skin healthy7.
What this guide deliberately does not tell you
It does not tell you how many units to inject, how many nights a week, or for how long — because those are clinical decisions, and because sermorelin's adult use rests on weak evidence. The strongest adult-relevant study gave nightly subcutaneous GHRH(1-29) to older men and found it raised growth hormone but did not significantly change body composition5; the robust dosing data come from children with a diagnosed deficiency, not healthy adults4. Sermorelin also works through the growth-hormone/IGF-1 axis, so a prescriber should be checking baseline labs and monitoring IGF-1 and glucose while you use it8 — monitoring you cannot do from an injection guide. People with active or recent cancer, and anyone pregnant, should not be using GH-axis stimulators off-label; we treat the cancer question in depth in does sermorelin cause cancer?.
The bottom line
Injecting sermorelin correctly is mostly about respecting a fragile peptide: reconstitute it gently without shaking, store it exactly as your pharmacy directs, draw the dose your prescriber set, and inject it subcutaneously at bedtime with a short needle while rotating sites to protect your skin67. The mechanics are routine; the dose and the decision to use it are not, and they belong to a clinician who can monitor your labs. If you are still weighing whether and where to get sermorelin at all, start with our pillar guide and our honest ranking of the best sermorelin providers.
Frequently asked questions
How do you inject sermorelin?
Sermorelin is reconstituted from a lyophilized powder with the diluent your pharmacy supplies (mixed by gently rolling the vial, never shaking), then injected subcutaneously — usually into the abdomen or thigh at bedtime — with a short, fine insulin needle, rotating to a fresh site each time. The dose itself must be the one your prescriber set, not a number from a chart.
Where do you inject sermorelin?
Into subcutaneous fat — most commonly the abdomen (a couple of inches away from the navel) or the thigh. Injection-technique guidance stresses rotating sites with each dose to avoid lipohypertrophy, the lumpy scarred tissue that forms from repeated injections in one spot and can make absorption unpredictable.
Does sermorelin have to be mixed before injecting?
Yes. It is supplied as a freeze-dried powder that must be reconstituted with sterile or bacteriostatic water before use. Add the diluent slowly down the vial wall and mix by rolling gently — shaking can foam and damage the peptide. Use only a clear, particle-free solution, and follow your pharmacy's storage and beyond-use instructions.
What time of day should sermorelin be injected?
The studied regimens use bedtime dosing, because growth hormone is naturally released in its largest pulses during early sleep and a nighttime injection is meant to reinforce that pulse. This is also why sermorelin's plausible effects cluster around sleep and recovery rather than daytime performance. Confirm timing with your prescriber.
Notes & sources
- Prakash A, Goa KL (1999). Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.. BioDrugs. https://pubmed.ncbi.nlm.nih.gov/18031173/
- Rafferty B, Poole S, Clarke R, Schulster D (1988). Pharmacokinetic evaluation of superactive analogues of growth hormone-releasing factor (1-29)-amide.. Peptides. https://pubmed.ncbi.nlm.nih.gov/2896343/
- Munafo A, Nguyen TX, Papasouliotis O, Lécuelle H, Priestley A, Thorner MO (2005). Polyethylene glycol-conjugated growth hormone-releasing hormone is long acting and stimulates GH in healthy young and elderly subjects.. European Journal of Endocrinology. https://pubmed.ncbi.nlm.nih.gov/16061831/
- Thorner M, Rochiccioli P, Colle M, et al. (Geref International Study Group) (1996). Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy.. Journal of Clinical Endocrinology & Metabolism. https://pubmed.ncbi.nlm.nih.gov/8772599/
- Vittone J, Blackman MR, Busby-Whitehead J, et al. (1997). Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.. Metabolism. https://pubmed.ncbi.nlm.nih.gov/9005976/
- Theratechnologies (manufacturer label) (2019). EGRIFTA SV (tesamorelin) for injection — FDA prescribing information (Dosage and Administration: reconstitution, subcutaneous injection, site rotation, storage).. DailyMed (NIH/NLM), FDA label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d783378-b02d-4f19-99dd-0fc91a042224
- Frid AH, Kreugel G, Grassi G, et al. (2016). New Insulin Delivery Recommendations.. Mayo Clinic Proceedings. https://pubmed.ncbi.nlm.nih.gov/27594187/
- Falutz J, Allas S, Blot K, et al. (2007). Metabolic effects of a growth hormone-releasing factor in patients with HIV.. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/18057338/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Also in this collection
Sermorelin for Sleep, Recovery & Healthy Aging
An honest, evidence-based look at sermorelin: what it is, the GHRH-sleep mechanism, the thin clinical record, and what it does and doesn't prove.
ReadDoes Sermorelin Improve Deep Sleep?
GHRH can boost slow-wave sleep in research settings, but the effect fades with age and large sermorelin sleep trials don't exist. An honest review.
ReadDoes Sermorelin Build Muscle or Burn Fat?
The best-matched human trial of nightly GHRH(1-29) raised GH but showed no IGF-1 or body-composition benefit. An honest look at the muscle and fat claims.
ReadIs Sermorelin Really 'Anti-Aging'?
Growth hormone in healthy elderly gives marginal benefit with more side effects, and lower lifelong GH/IGF-1 tracks with longevity. The cautious truth.
ReadTesamorelin vs Sermorelin: How They Actually Differ
Tesamorelin is FDA-approved for HIV visceral fat; sermorelin is compounded and off-label. Same GHRH mechanism, very different evidence — an honest comparison.
ReadSermorelin vs Ipamorelin: Evidence Compared
Sermorelin is a compounded GHRH analog; ipamorelin a ghrelin-receptor secretagogue. Different receptors, different evidence — an honest comparison.
ReadOral & Sublingual Sermorelin: Does It Actually Work?
Oral and sublingual sermorelin are sold as needle-free options, but peptide absorption is brutally poor. The honest pharmacology and the real GHRH route data.
ReadSermorelin Before & After: What to Realistically Expect
No dramatic transformation photos here — just what the evidence actually supports, a realistic week-by-week timeline, and where the marketing overreaches.
ReadDoes Sermorelin Cause Cancer? What the Evidence Says
Sermorelin raises GH and IGF-1, and IGF-1 is linked to some cancers. No trial shows sermorelin causes cancer — but the unknowns and contraindications are real.
ReadSermorelin Dosing: What the Research Actually Supports
What the trials actually show on sermorelin doses: 1 mcg/kg diagnostic, 30 mcg/kg/day in children. There is no validated adult anti-aging dose.
ReadIpamorelin Side Effects: What the Data Actually Shows
Ipamorelin's selling point is fewer side effects than older GHRPs. Here's what's proven in humans, what's extrapolated, and the gaps that matter.
Read